Abstract
In 1976, Matthews et al.19 reported the antiviral activity of milk proteins, underlining their possible clinical importance. Only recently, this effect has been ascribed mainly to lactoferrin (Lf). Lf was initially shown to exert a protective influence in mice infected with Friend leukemia virus15. Subsequently, a potent antiviral activity has been attributed to Lf, both in vitro towards cytomegalovirus (HCMV)9,7, herpes simplex virus (HSV)17, human immunodeficiency virus (HIV)7,29 and in vivo towards HSV-16 and HCMV25. Our groups provided evidence on the antiviral activity of Lf towards HSV-218, rotavirus28, and HIV22 infections (Table 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balogh-Nair V, Brathwaite CE, Chen CX, Vargas J Jr (1995) Synthesis, activity and toxicity of novel macrocyclic ligands against HIV-1 in Jurkat and CEM-SS cell lines. Cell Mol Biol 41 Suppl I: 9–14
Cinatl J Jr, Cinatl J, Rabenau H, Gumbel HO, Kornhuber B, Doerr HW (1994) 1n ritro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res 25: 73–77
Comerie-Smith SE, Nunez J, Hosmer M, Farris RL (1994) Tear lactoferrin and ocular bacterial flora in HIV positive patients. Adv Exp Med Biol 350: 339–344
Davidson LA, Lonnerdal B (1989) Fe saturation and proteolysis of human lactoferrin: effect on brushborder receptor mediated uptake of Fe” and Mn’’. Am J Physiol 257: G930 - G934
Defer MC, Dugas B, Picard O, Damais C (1995) Impairment of circulating lactoferrin in HIV-infection. Cell Mol Biol 41: 417–421
Fujihara T and Hayashi K (1995) Lactoferrin inhibits herpes simplex virus type-1 (FISV-1) infection to mouse cornea. Arch Virol 140: 1469–72
Harmsen MC, Swart PJ, de Béthune MP, Pawcls R, De Clereq E, The TI I, Meijer DKF (1995) Antiviral effects of plasma and milk proteins: lactoferrin shows a potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 172: 380–388
Harrington JP (1992) Spectroscopic analysis of the unfolding of transition metal-ion complexes of human lactoferrin and transfer-in. Int J Biochem 24: 275–28(1
Hasegawa K. Motsuchi W. Tanaka S, Dosako S (1994) Inhibition with lactoferrin of in vitro infection with human herpes viruslpn. J Med Sci Biol 47: 73–85
Hu W-I., Mazuricr.I, Montreuil J. Spik G (1990) Isolation and partial characterization of a lactotransferrin receptor From mouse intestinal brush border. Biochemistry 29: 535–541
Inouye Y, Kanamori T, Yoshida T, Bu X, Shionoya NI, Koike T, Kimura E (1994) Inhibition of human immunodeficiency virus proliferation by macrocyclic polyamines and their metal complexes. Biol Pharm 13u11 17: 243 250
Ji Z.S. and Willey R.W. (1994) Lactoferrin binding to heparan sulphate proteoglycans and LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. A rterioscler Thromb 14, 2025–2031
Liuzzi M, D,/Eeziel R, Moss N, Beaulieu P, Bonneau AM, Bousquet C, Chafouleas JG, Garneau M, Jaramillo J, Krogsrud RL. et al. (1994) A potent peptidomimetic inhibitor of HSV ribonucleotide reductase With antiviral activity in vivo. Nature 372: 6507–6508
Longhi C, Conte MR Seganti, Polidoro M, Alfsen A, Valenti P (1993) Influence of lactoferrin on the entry process of Escherichia co/i HB 101 (pRI203) in I leLa cells. Med Microbiol Immunol 182: 25–35
Lu L, Hangoc G, Oliff A. Chen L, Shen RN, Broxmeyer HE (1987) Protective influence of lactoferrin on mice infected with the polythemia-inducing strain of Friend virus complex. Cancer Res 47: 4181 1 88
Mann DM, Romm E, Migliorini M (1994) Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J Biol Chem 269: 23661–23667
Marchetti M. Longhi C, Conte MP, Pisani S, Valenti P, Seganti L (1996) Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res 29: 221–231
Marchetti M. Pisani S, Antonini G, Valenti P, Seganti L, Orsi N In vitro inhibition of herpes simplex virus type I and 2 by bovine lactoferrin saturated with iron, manganese and zinc ions. Submitted for publication
Matthews THJ, Nair CDG, Lawrence MK, Tyrrel DAJ (1976) Antiviral activity in milk of possible clinical importance. Lancet 7: 1387–1389
Mikogami T, Heyman M. Spik G, Desjeux JF (1994) Apical-to-basolateral transepithelial transport of human lactoferrin in the intestinal cell line HT-29c1.I9A. Am i Physiol G308 - G3 I5
Nuijens JH,.Abbink JJ, Wachtfogel YT, Colman RW, Ecrenberg AJ, Dors D, Kamp AJ, Strack van Schijndel RJ, Thijs LG, Hack CE (1992) Plasma elastase alpha 1- antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis..1 Lab Clin Med 119: 159–68
Puddu P, Borghi P, Gessani S, Valenti P, Belardelli F, Seganti L Antiviral effect of bovine lactoferrin with divalent and trivalent metal ions on early steps of human immunodeficiency virus type I infection. Submitted for pubblication
Roderiqucz G. Oravecz T. Yanagishita M. Bou-Habib DC, Mostowski H, Norcross MA (1995) Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 69: 2233–2239.
Roiron, D, Amouric M, Marvaldi J, Figarella C (1989) Lactoferrin-binding sites at the surface of HT29–D4 cells. Eur J.Biochem 186: 367–373.
Shimizu K. Matsuzawa H, Okada K, Tazume S, Dosako S, Kawasaki Y, Hashimoto K, Koga Y (1996) Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch Virol 141: 1875–1889
Smith CA., Anderson BF. Baker HM, Baker EN (1992) Metal substitution in transferrins: the crystal structure of human copper-lactoferrin at 2.1-A resolution. Biochemistry 31: 4527–4533
Superti F, Donelli G (1995) Characterization of SA-11 rotavirus receptorial structures on human colon carcinoma cell line HT-29. J Med Virol 47: 421–428.
Superti F, Ammendolia MG, Valenti P, Seganti L Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus replication in the enterocyte-like cell line HT-29. Submitted for publication
Swart PJ, Kuipers ME, Smith C, Pawels R, de Béthune MP, De Clercq E, Meijer DKF Huisman JG (1996) Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res Human Retrov 12: 769–775
Wu HF, Monroe DM, Church FC (1995) Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch Biochem Biophys 317: 85–92
WuDunn D, Spear PG (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulphate. J Virol 63: 52–58
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Valenti, P. et al. (1998). Antiviral Activity of Lactoferrin. In: Spik, G., Legrand, D., Mazurier, J., Pierce, A., Perraudin, JP. (eds) Advances in Lactoferrin Research. Advances in Experimental Medicine and Biology, vol 443. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9068-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9068-9_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9070-2
Online ISBN: 978-1-4757-9068-9
eBook Packages: Springer Book Archive